1,368 results on '"Wilde, A. A.M."'
Search Results
2. An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia
3. Comparing adolescent- and adult-onset unexplained cardiac arrest: Results from the Dutch Idiopathic VF Registry
4. ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy
5. Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial
6. Safety of Sports for Patients with Subcutaneous Implantable Cardioverter Defibrillator (SPORT S-ICD): study rationale and protocol
7. Prediction of sudden cardiac death using artificial intelligence: Current status and future directions
8. Effect of posture on position of subcutaneous implantable cardioverter-defibrillator
9. Dynamic prediction of malignant ventricular arrhythmias using neural networks in patients with an implantable cardioverter-defibrillator
10. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study
11. Provocation testing in congenital long QT syndrome: A practical guide
12. Clinical Management of Brugada Syndrome: Commentary From the Experts
13. Toward advanced diagnosis and management of inherited arrhythmia syndromes: Harnessing the capabilities of artificial intelligence and machine learning
14. Novelties in Brugada Syndrome: Complex Genetics, Risk Stratification, and Catheter Ablation
15. Catecholaminergic Polymorphic Ventricular Tachycardia: A Review of Therapeutic Strategies
16. Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
17. Response by Nademanee et al to Letter Regarding Article, “Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)”
18. Five-year safety and efficacy of leadless pacemakers in a Dutch cohort
19. Risk Stratification in Brugada Syndrome: How Low Can We Go?
20. Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy
21. Clinical applicability of artificial intelligence for patients with an inherited heart disease: A scoping review
22. Predicted Need for Atrial and Ventricular Pacing Per Indication Group in Patients With Dual-Chamber Pacemakers
23. Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome
24. Accuracy and clinical relevance of the single-lead Apple Watch electrocardiogram to identify atrial fibrillation
25. COVID-19 vaccination in patients with long QT syndrome
26. The Sports Cardiology Team: Personalizing Athlete Care Through a Comprehensive, Multidisciplinary Approach
27. Value of genetic testing in the diagnosis and risk stratification of arrhythmogenic right ventricular cardiomyopathy
28. Predicting arrhythmia recurrence following catheter ablation for ventricular tachycardia using late gadolinium enhancement magnetic resonance imaging: Implications of varying scar ranges
29. Sex hormones and repolarization dynamics during the menstrual cycle in women with congenital long QT syndrome
30. Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation
31. Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)
32. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases
33. Congenital Long QT Syndrome
34. Long-term performance of a novel communicating antitachycardia pacing–enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study
35. Arrhythmogenic Right Ventricular Cardiomyopathy
36. Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy
37. A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome
38. Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiograms
39. Tissues attached to retrieved leadless pacemakers: Histopathological evaluation of tissue composition in relation to implantation time and complications
40. Predicting Post-Infarct Ventricular Tachycardia by Integrating Cardiac MRI and Advanced Computational Reentrant Pathway Analysis
41. Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia
42. Echocardiographic deformation imaging unmasks global and regional mechanical dysfunction in patients with idiopathic ventricular fibrillation: A multicenter case-control study
43. Diagnostic accuracy of the response to the brief tachycardia provoked by standing in children suspected for long QT syndrome
44. Improving electrocardiogram-based detection of rare genetic heart disease using transfer learning: An application to phospholamban p.Arg14del mutation carriers
45. Fractionated Epicardial Electrograms: Implication for Mechanism of the Brugada Pattern
46. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families
47. Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?
48. Mitral annular disjunction in idiopathic ventricular fibrillation patients: Just a bystander or a potential cause?
49. Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients:a position statement by the Task Force of the Dutch Society of Cardiology
50. Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia:a landmark study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.